| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
| filingDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f108a9b9d2be6ea21ff0b97d907a541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ab472e6b8417ba7f0898feec5109a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03042b5537640ea143cbf308fc4107f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44dcdb1e01eecfc84750545a635de3ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8484987de6e9daa8194f4d97f849f714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6eaf36c8cfa11f6b011e7b9430bb77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf94f56be7d880aa0a9dba6927b93bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c859989f0edb908d79238986cda83d |
| publicationDate |
2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1682181-A2 |
| titleOfInvention |
Combination of a vegf receptor inhibitor with a chemotherapeutic agent |
| abstract |
The present invention relates to a combination therapy for treating patients suffering from proliferative diseases or diseases associated with persistent angiogenesis. The patient is treated with a VEGF inhibitor compound; and one or more chemotherapeutic agents. |
| priorityDate |
2003-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |